Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type G(i)-linked P2T antagonist, CS-747 (Q28345809)

1

0 references

F Asai

2

0 references

K Yoneda

3

0 references

R Iwamura

4

0 references

T Ogawa

5

0 references

K Otsuguro

6

0 references

H Koike

British Journal of Pharmacology

7

0 references

language of work or name

English

0 references

publication date

January 2001

0 references

published in

0 references

volume

132

0 references

issue

1

0 references

page(s)

47-54

0 references

cites work

A new generation of Ca2+ indicators with greatly improved fluorescence properties

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572523

ADP can induce aggregation of human platelets via both P2Y(1) and P(2T) receptors

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572523

P2 receptor subtypes in the cardiovascular system

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572523

Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572523

P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572523

Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572523

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572523

Receptors for ADP on human blood platelets.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572523

Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572523

The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572523

Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572523

Identification of competitive antagonists of the P2Y1 receptor.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572523

Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572523

Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572523

Activation of receptor-operated cation channels via P2X1 not P2T purinoceptors in human platelets

27 November 2018

1 reference

12 December 2020

Megakaryocytopoiesis and platelet production are stimulated during late pregnancy and early postpartum in the rat

1 reference

12 December 2020

Non-specific inhibition of ADP-induced platelet antiaggregation by clopidogrel in vitro

1 reference

12 December 2020

Effect of ticlopidine on platelet aggregation, adherence to damaged vessels, thrombus formation and platelet survival

1 reference

12 December 2020

Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine

1 reference

12 December 2020

The P2Y1 receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation

1 reference

12 December 2020

Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation

1 reference

12 December 2020

Functional characterization of platelet ADP receptors

1 reference

12 December 2020

ADP induced blood platelet activation: a review

1 reference

12 December 2020

Ticlopidine selectively inhibits human platelet responses to adenosine diphosphate

1 reference

12 December 2020

ADP receptors on platelets

1 reference

12 December 2020

Inhibition of rat platelet aggregation by mycalolide-B, a novel inhibitor of actin polymerization with a different mechanism of action from cytochalasin-D

1 reference

12 December 2020

Multiple P2 receptor subtypes on platelets: a new interpretation of their function

1 reference

12 December 2020

Ticlopidine and clopidogrel (SR 25990C) selectively neutralize ADP inhibition of PGE1-activated platelet adenylate cyclase in rats and rabbits

1 reference

12 December 2020

The antiaggregating activity of clopidogrel is due to a metabolic activation by the hepatic cytochrome P450-1A

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJP.0703761

1 reference

1 reference

1 reference

PubMed publication ID

11156560

1 reference